Processa Pharmaceuticals, Inc.
PCSA
Last
$1.36
Day
+0.7%
1y
-86.2%
5y
-100.0%
52w
-87.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
1.69
EMA 50
1.92
EMA 200
3.56
20d high
-36.0%
5y high
-100.0%
5y range
0th
Positions held
Your positionsPCSA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.58
Stop
$1.15
Stop distance
15.4%
Target vs last
+16.2%
Fundamentals
| Market cap | $3.77M | Enterprise value | $3.57M | Trailing P/E | — | Forward P/E | -0.36 |
| PEG | — | Price / book | -11.84 | Beta | 1.20 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -4.6% | ROA | -1.6% | Debt / equity | — |
| Current ratio | 0.87 | Free cash flow | -$8.74M | Analyst recommendation | none | Mean target | — |
| 52w high | $11.08 | 52w low | $1.32 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$3.3M | -$3.4M | -$3.4M | -$3.4M | -$3.9M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.3M | -$3.3M | -$3.7M | -$3.5M | -$4.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$13.6M | -$11.9M | -$11.1M | -$27.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$14.0M | -$12.1M | -$11.5M | -$20.3M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsPCSA · daily-28.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin